Growth In The Siliq Market Is Being Driven By The Rise In Hormonal Imbalances Fueling The Growth Of The Due To Increasing Demand For Hormone Replacement Therapies

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Siliq Market In 2026 And 2030?

Historical growth has been influenced by a rising occurrence of moderate to severe plaque psoriasis, the constrained effectiveness of traditional systemic therapies, dermatologists increasingly adopting biologics, the expansion of specialized dermatology clinics, and enhanced diagnosis rates.

Anticipated expansion during the forecast period stems from the heightened demand for advanced biologics, a greater emphasis on sustained disease control, the broadening availability of individualized immune therapies, increased funding for research into inflammatory conditions, and improved patient access to specialized treatments.

Significant trends anticipated during the projection period involve the growing uptake of precision biologic treatments, the expanding application of IL-17 pathway inhibitors, enhanced attention to individualized psoriasis care, the widening reach of specialty pharmacy networks, and more comprehensive tracking of therapeutic results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20265&type=smp

Which Key Drivers Are Affecting The Siliq Market Development?

The rising occurrence of skin conditions is expected to drive the expansion of the Siliq market in the future. Skin disease encompasses diverse ailments impacting the skin’s structure, performance, or look, frequently resulting from infections, inflammation, hereditary elements, autoimmune issues, or external factors. This uptick in skin disease cases stems from elements such as shifts in the environment, escalating pollution, greater sun exposure, genetic tendencies, and lifestyle aspects like inadequate nutrition and high stress. Siliq offers advantages for skin diseases, especially for moderate to severe plaque psoriasis, by targeting particular immune system pathways to diminish inflammation, enhance skin appearance, and relieve signs like redness, scaling, and itching. For example, in January 2024, the American Cancer Society, a US-based non-profit organization dedicated to eradicating cancer, forecast 108,270 documented cases of skin cancer, indicating a 3.2% rise from the 104,930 cases noted in 2023. Consequently, the heightened prevalence of skin disease is boosting the Siliq market’s development.

Siliq Market Driver: Rising Geriatric Demographics Fueling Demand For Siliq In Psoriasis Treatment

The expanding senior demographic is expected to propel the Siliq market’s growth. The geriatric population generally includes individuals aged 65 years or more, though this age criterion can differ based on context or health sector norms. The increase in the geriatric population results from longer life expectancies, improvements in medical care, and decreasing birth rates, leading to a greater share of older people worldwide. Siliq offers benefits for the elderly by providing an efficient treatment solution for moderate to severe plaque psoriasis, assisting in symptom management and enhancing skin health for older adults who might have fewer treatment choices due to age-related medical issues. As an illustration, in July 2024, figures from the UK Parliament’s House of Commons Library, a UK-based government administrative body, indicated that in 2022, the UK contained 12.7 million people aged 65 and above, constituting 19% of its total populace. By 2072, this figure is projected to rise to 22.1 million, or 27% of the population. Thus, the expanding geriatric population is fostering the growth of the Siliq market.

What Are The Key Segment Divisions In The Siliq Market Segment Structure?

The siliq market covered in this report is segmented –

1) By Clinical Indication: Moderate To Severe Plaque Psoriasis, Other Indications

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies

3) By End-User: Hospitals, Specialty Clinics, Home Care Settings

Which Organizations Are Engaged In The Siliq Market?

Major companies operating in the siliq market are Valeant Pharmaceuticals International Inc.

Get The Full Siliq Market Report:

https://www.thebusinessresearchcompany.com/report/siliq-global-market-report

Which Geographic Region Dominates The Siliq Market?

North America was the largest region in the siliq market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the siliq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Siliq Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/siliq-global-market-report

Browse Through More Reports Similar to the Global Siliq Market 2026, By The Business Research Company

In Silico Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-silico-clinical-trials-global-market-report

Silanes Market Report 2026

https://www.thebusinessresearchcompany.com/report/silanes-global-market-report

Automotive Silicone Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-silicone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795